SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Nu Skin Enterprises, Inc. – ‘10-K’ for 12/31/23 – ‘EX-97.1’

On:  Wednesday, 2/14/24, at 9:52pm ET   ·   As of:  2/15/24   ·   For:  12/31/23   ·   Accession #:  1140361-24-8111   ·   File #:  1-12421

Previous ‘10-K’:  ‘10-K’ on 2/16/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   14 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/15/24  Nu Skin Enterprises, Inc.         10-K       12/31/23  128:15M                                    Broadridge Fin’l So… Inc

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.05M 
 2: EX-4.2      Description of Registrant's Securities              HTML     46K 
 5: EX-10.13    Executive Severance Policy                          HTML    181K 
 3: EX-10.5     Form of Third Amended and Restated 2010 Plan Rsu    HTML    147K 
                Grant Agreement                                                  
 4: EX-10.6     Form of Third Amended and Restated 2010 Plan Prsu   HTML    145K 
                Grant Agreement                                                  
 6: EX-21.1     Subsidiaries of the Company                         HTML     40K 
 7: EX-23.1     Consent of Pricewaterhousecoopers LLP               HTML     34K 
12: EX-97.1     Executive Officer Incentive Compensation Recovery   HTML     53K 
                Policy                                                           
 8: EX-31.1     Section 302 Certification of Chief Executive        HTML     41K 
                Officer                                                          
 9: EX-31.2     Section 302 Certification of Chief Financial        HTML     41K 
                Officer                                                          
10: EX-32.1     Section 906 Certification of Chief Executive        HTML     35K 
                Officer                                                          
11: EX-32.2     Section 906 Certification of Chief Financial        HTML     35K 
                Officer                                                          
18: R1          Document and Entity Information                     HTML    104K 
19: R2          Consolidated Balance Sheets                         HTML    136K 
20: R3          Consolidated Balance Sheets (Parenthetical)         HTML     42K 
21: R4          Consolidated Statements of Income                   HTML    106K 
22: R5          Consolidated Statements of Comprehensive Income     HTML     63K 
23: R6          Consolidated Statements of Comprehensive Income     HTML     42K 
                (Parenthetical)                                                  
24: R7          Consolidated Statements of Stockholders' Equity     HTML     82K 
25: R8          Consolidated Statements of Stockholder's Equity     HTML     37K 
                (Parenthetical)                                                  
26: R9          Consolidated Statements of Cash Flows               HTML    134K 
27: R10         The Company                                         HTML     38K 
28: R11         Summary of Significant Accounting Policies          HTML    176K 
29: R12         Property and Equipment                              HTML     53K 
30: R13         Goodwill                                            HTML     55K 
31: R14         Other Intangible Assets                             HTML     67K 
32: R15         Long-Term Debt                                      HTML     54K 
33: R16         Leases                                              HTML     79K 
34: R17         Capital Stock                                       HTML     55K 
35: R18         Stock-Based Compensation                            HTML    140K 
36: R19         Fair Value and Equity Investments                   HTML     92K 
37: R20         Income Taxes                                        HTML    149K 
38: R21         Employee Benefit Plan                               HTML     41K 
39: R22         Deferred Compensation Plan                          HTML     41K 
40: R23         Derivative Financial Instruments                    HTML     59K 
41: R24         Segment Information                                 HTML    191K 
42: R25         Commitments and Contingencies                       HTML     40K 
43: R26         Other Income (Expense), Net                         HTML     37K 
44: R27         Supplemental Cash Flow Information                  HTML     37K 
45: R28         Acquisitions                                        HTML     42K 
46: R29         Restructuring and Severance Charges                 HTML     82K 
47: R30         Insider Trading Arrangements                        HTML     40K 
48: R31         Summary of Significant Accounting Policies          HTML    179K 
                (Policies)                                                       
49: R32         Summary of Significant Accounting Policies          HTML    139K 
                (Tables)                                                         
50: R33         Property and Equipment (Tables)                     HTML     52K 
51: R34         Goodwill (Tables)                                   HTML     56K 
52: R35         Other Intangible Assets (Tables)                    HTML     70K 
53: R36         Long-Term Debt (Tables)                             HTML     56K 
54: R37         Leases (Tables)                                     HTML     81K 
55: R38         Capital Stock (Tables)                              HTML     46K 
56: R39         Stock-Based Compensation (Tables)                   HTML    142K 
57: R40         Fair Value and Equity Investments (Tables)          HTML     90K 
58: R41         Income Taxes (Tables)                               HTML    152K 
59: R42         Derivative Financial Instruments (Tables)           HTML     57K 
60: R43         Segment Information (Tables)                        HTML    194K 
61: R44         Restructuring and Severance Charges (Tables)        HTML     81K 
62: R45         The Company (Details)                               HTML     39K 
63: R46         Summary of Significant Accounting Policies,         HTML     55K 
                Inventories (Details)                                            
64: R47         Summary of Significant Accounting Policies,         HTML     57K 
                Prepaid Expenses and Other (Details)                             
65: R48         Summary of Significant Accounting Policies,         HTML     54K 
                Property and Equipment (Details)                                 
66: R49         Summary of Significant Accounting Policies,         HTML     45K 
                Goodwill and Other Intangible Assets (Details)                   
67: R50         Summary of Significant Accounting Policies, Other   HTML     53K 
                Assets (Details)                                                 
68: R51         Summary of Significant Accounting Policies,         HTML     61K 
                Accrued Expenses (Details)                                       
69: R52         Summary of Significant Accounting Policies, Other   HTML     54K 
                Liabilities (Details)                                            
70: R53         Summary of Significant Accounting Policies,         HTML     40K 
                Revenue Recognition (Details)                                    
71: R54         Summary of Significant Accounting Policies,         HTML     39K 
                Contract Liabilities - Customer Loyalty Programs                 
                (Details)                                                        
72: R55         Summary of Significant Accounting Policies,         HTML     38K 
                Advertising Expenses (Details)                                   
73: R56         Summary of Significant Accounting Policies,         HTML     37K 
                Research and Development (Details)                               
74: R57         Summary of Significant Accounting Policies,         HTML     69K 
                Uncertain Tax Positions (Details)                                
75: R58         Summary of Significant Accounting Policies,         HTML     40K 
                Foreign Currency Translation (Details)                           
76: R59         Summary of Significant Accounting Policies,         HTML     42K 
                Classification of a Highly Inflationary Economy                  
                (Details)                                                        
77: R60         Summary of Significant Accounting Policies, Fair    HTML     36K 
                Value of Financial Instruments (Details)                         
78: R61         Summary of Significant Accounting Policies,         HTML     40K 
                Stock-Based Compensation (Details)                               
79: R62         Property and Equipment (Details)                    HTML     70K 
80: R63         Goodwill (Details)                                  HTML     56K 
81: R64         Other Intangible Assets, Indefinite Life            HTML     38K 
                Intangible Assets (Details)                                      
82: R65         Other Intangible Assets, Finite Life Intangible     HTML     63K 
                Assets (Details)                                                 
83: R66         Other Intangible Assets, Annual Estimated Future    HTML     62K 
                Amortization Expense (Details)                                   
84: R67         Long- Term Debt, Credit Agreement (Details)         HTML     70K 
85: R68         Long-Term Debt, Debt Facilities (Details)           HTML     69K 
86: R69         Long-Term Debt, Maturities of Long-Term Debt        HTML     57K 
                (Details)                                                        
87: R70         Leases (Details)                                    HTML    131K 
88: R71         Capital Stock, Authorized Capital Stock (Details)   HTML     55K 
89: R72         Capital Stock, Weighted Average Shares Outstanding  HTML     50K 
                (Details)                                                        
90: R73         Capital Stock, Dividends (Details)                  HTML     74K 
91: R74         Capital Stock, Repurchases of Common Stock          HTML     49K 
                (Details)                                                        
92: R75         Stock-Based Compensation, Equity Incentive Plans    HTML     44K 
                (Details)                                                        
93: R76         Stock-Based Compensation, Stock Option Valuation    HTML     55K 
                Assumptions (Details)                                            
94: R77         Stock-Based Compensation, Stock Options (Details)   HTML     95K 
95: R78         Stock-Based Compensation, Stock Options Exercised   HTML     42K 
                (Details)                                                        
96: R79         Stock-Based Compensation, Nonvested Restricted and  HTML     64K 
                Performance Stock Awards (Details)                               
97: R80         Stock-Based Compensation, Stock-Based Compensation  HTML     55K 
                Expense (Details)                                                
98: R81         Fair Value and Equity Investments, Fair Value       HTML     85K 
                (Details)                                                        
99: R82         Fair Value and Equity Investments, Equity           HTML     43K 
                Investments (Details)                                            
100: R83         Income Taxes, Consolidated Income Before Provision  HTML     44K  
                for Income Taxes (Details)                                       
101: R84         Income Taxes, Current and Deferred Taxes (Details)  HTML     62K  
102: R85         Income Taxes, Deferred Tax Assets and Liabilities   HTML    106K  
                (Details)                                                        
103: R86         Income Taxes, Deferred Tax Asset Valuation          HTML     58K  
                Adjustments (Details)                                            
104: R87         Income Taxes, Deferred Taxes, Net of a              HTML     41K  
                Jurisdiction Basis (Details)                                     
105: R88         Income Taxes, Reconciliation of Statutory to        HTML     71K  
                Effective Tax Rate (Details)                                     
106: R89         Employee Benefit Plan (Details)                     HTML     54K  
107: R90         Deferred Compensation Plan (Details)                HTML     67K  
108: R91         Derivative Financial Instruments, Fair Value of     HTML     51K  
                Derivative Instruments on the Balance Sheet                      
                (Details)                                                        
109: R92         Derivative Financial Instruments, Effect of Cash    HTML     48K  
                Flow Hedge Accounting on Accumulated Other                       
                Comprehensive Income (Details)                                   
110: R93         Segment Information, Revenue by Segment (Details)   HTML     80K  
111: R94         Segment Information, Segment Contribution           HTML     73K  
                (Details)                                                        
112: R95         Segment Information, Depreciation and Amortization  HTML     72K  
                and Capital Expenditures (Details)                               
113: R96         Segment Information, Revenue by Major Market        HTML     56K  
                (Details)                                                        
114: R97         Segment Information, Revenue by Product Line        HTML     45K  
                (Details)                                                        
115: R98         Segment Information, Long-Lived Assets by Major     HTML     48K  
                Market (Details)                                                 
116: R99         Other Income (Expense), Net (Details)               HTML     40K  
117: R100        Supplemental Cash Flow Information (Details)        HTML     39K  
118: R101        Acquisitions, LifeDNA (Details)                     HTML     83K  
119: R102        Acquisitions, BeautyBio (Details)                   HTML    107K  
120: R103        Acquisitions, Revenue and Pro Forma Revenue         HTML     42K  
                (Details)                                                        
121: R104        Restructuring and Severance Charges, 2021           HTML     62K  
                Restructuring Plan (Details)                                     
122: R105        Restructuring and Severance Charges, 2022           HTML     96K  
                Restructuring Plan (Details)                                     
123: R106        Restructuring and Severance Charges, 2023           HTML     83K  
                Restructuring Plan (Details)                                     
125: XML         IDEA XML File -- Filing Summary                      XML    227K  
128: XML         XBRL Instance -- ef20015265_10k_htm                  XML   3.56M  
124: EXCEL       IDEA Workbook of Financial Report Info              XLSX    228K  
14: EX-101.CAL  XBRL Calculations -- nus-20231231_cal                XML    328K 
15: EX-101.DEF  XBRL Definitions -- nus-20231231_def                 XML   1.29M 
16: EX-101.LAB  XBRL Labels -- nus-20231231_lab                      XML   2.99M 
17: EX-101.PRE  XBRL Presentations -- nus-20231231_pre               XML   1.96M 
13: EX-101.SCH  XBRL Schema -- nus-20231231                          XSD    256K 
126: JSON        XBRL Instance as JSON Data -- MetaLinks              742±  1.12M  
127: ZIP         XBRL Zipped Folder -- 0001140361-24-008111-xbrl      Zip    836K  


‘EX-97.1’   —   Executive Officer Incentive Compensation Recovery Policy


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 

Exhibit 97.1

NU SKIN ENTERPRISES, INC.
Executive Officer Incentive Compensation Recovery Policy

A.    Purpose
 
The Compensation and Human Capital Committee (the “Committee”) of the Board of Directors (the “Board”) of Nu Skin Enterprises, Inc., a Delaware corporation (the “Company”), has adopted this policy (this “Policy”) to require the recovery of certain executive compensation in the event that the Company is required to prepare an Accounting Restatement.  This Policy is designed to comply with Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rule 10D-1 thereunder, and Section 303A.14 of the New York Stock Exchange (the “NYSE”) Listed Company Manual (“Section 303A.14”) and will be interpreted and applied accordingly.
 
B.    Administration
 
This Policy will be administered by the Committee.  The Committee is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy.  Any determinations made by the Committee will be final and binding on all affected individuals. Any members of the Committee, and any other members of the Board who assist in the administration of this Policy, shall not be personally liable for any action, determination or interpretation made with respect to this Policy and shall be fully indemnified by the Company to the fullest extent under applicable law and Company policy with respect to any such action, determination or interpretation. The foregoing sentence shall not limit any other rights to indemnification of the members of the Board under applicable law or Company policy.
 
C.    Covered Executives
 
This Policy applies to the Company’s current and former “officers” as determined pursuant to Rule 16a‑1(f) promulgated under the Exchange Act and including “executive officers” identified under Item 401(b) of Regulation S-K (“Executive Officers,” and together with any former Executive Officer, the “Covered Executives”).
 
D.    Recoupment upon an Accounting Restatement
 
In the event that the Company is required to prepare an Accounting Restatement, the Company will recover reasonably promptly all Erroneously Awarded Compensation from each Covered Executive, unless the Committee determines that such recovery is Impracticable.
 
For purposes of the foregoing and all other provisions of this Policy:
 

1.
Accounting Restatement” means an accounting restatement of any of the Company’s financial statements due to the Company’s material noncompliance with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or to correct an error that is not material to previously issued financial statements, but would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period, within the meaning of Rule 10D-1 and Section 303A.14.



2.
Covered Incentive Compensation” means Incentive Compensation that is Received on or after October 2, 2023 by a person: (i) after beginning service as an Executive Officer, (ii) who served as an Executive Officer at any time during the performance period for that Incentive Compensation, (iii) while the Company has a class of securities listed on a national securities exchange or a national securities association, and (iv) during the three completed fiscal years immediately preceding the date that the Company is required to prepare the Accounting Restatement (or such longer period as required under Section 303A.14 in the event the Company changes its fiscal year).  The date that the Company is required to prepare the Accounting Restatement will be the earlier of (x) the date the Board concluded or reasonably should have concluded that the Accounting Restatement is required and (y) the date a court, regulator or other authorized body directs the Company to prepare the Accounting Restatement.


3.
Erroneously Awarded Compensation” means the amount of Covered Incentive Compensation that was Received by each Covered Executive in excess of the Covered Incentive Compensation that would have been Received by the Covered Executive had such Covered Incentive Compensation been determined based on the restated Financial Reporting Measure following an Accounting Restatement, computed without regard to taxes paid.  For this purpose, if the amount of Covered Incentive Compensation that is Received by a Covered Executive was based on the Company’s stock price or total shareholder return and is not subject to mathematical recalculation directly from the Accounting Restatement, the amount to be recovered as Erroneously Awarded Compensation shall be based on a reasonable estimate of the effect of the Accounting Restatement on the Financial Reporting Measure upon which the Covered Incentive Compensation was Received.  The Company’s Corporate Secretary shall, on behalf of the Committee, obtain and maintain all documentation of the determination of any such reasonable estimate and provide such documentation to the NYSE when required.


4.
Financial Reporting Measure” means (i) any measure that is determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements and any measure that is derived wholly or in part from any such measure, and (ii) the Company’s stock price and the total shareholder return of the Company.  A measure, however, need not be presented within the financial statements or included in a filing with the U.S. Securities and Exchange Commission (“SEC”) to constitute a Financial Reporting Measure.


5.
Impracticable” means that (i) the direct expense paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered, (ii) recovery would violate an applicable home country law adopted prior to November 28, 2022, or (iii) recovery would likely cause an otherwise tax-qualified, broad-based retirement plan of the Company to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and regulations thereunder.  Before concluding that it would be impracticable to recover any Erroneously Awarded Compensation based on the expense of enforcement, the Company shall make a reasonable attempt to recover such Erroneously Awarded Compensation, and the Company’s Corporate Secretary, on behalf of the Committee, shall document such reasonable attempt(s) to recover and provide that documentation to the NYSE when required.  Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on violation of law, the Committee shall engage legal counsel experienced and qualified to practice law in the applicable jurisdiction (if such counsel is acceptable to the NYSE) to render an opinion that recovery would result in a violation of law and shall provide such opinion to the NYSE.  The Company shall provide funding for the fees and expenses of such legal counsel as approved by the Committee.


6.
Incentive Compensation” means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure. For the avoidance of doubt, Incentive Compensation shall also be deemed to include any amounts which were determined based on (or were otherwise calculated by reference to) Incentive Compensation (including, without limitation, any amounts under any long-term disability, life insurance or supplemental retirement plan or any notional account that is based on Incentive Compensation, as well as any earnings accrued thereon).



7.
Received”: Incentive Compensation is deemed “received” in the Company’s fiscal period during which the Financial Reporting Measure specified in such Incentive Compensation is attained.

Recoupment of Erroneously Awarded Compensation pursuant to this Policy is made on a “no fault” basis, without regard to whether any misconduct occurred or whether any Covered Executive has responsibility for the noncompliance that resulted in the Accounting Restatement.
 
E.    Method of Recoupment
 
The Committee will determine, in its sole discretion, the method for recouping Erroneously Awarded Compensation hereunder, which may include, without limitation, any of the following, to the extent permitted by applicable law:
 

1.
Requiring reimbursement of cash Incentive Compensation previously paid;

2.
Seeking recovery of any gain or value realized on or since the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;

3.
Offsetting the recouped amount from any compensation otherwise owed by the Company to the Covered Executive (including, without limitation, any severance otherwise payable by the Company to the Covered Executive);

4.
Making a deduction from the Covered Executive’s salary;

5.
Requiring the Covered Executive to transfer back to the Company any shares he or she received pursuant to an equity award;

6.
Cancelling, or reducing the number of shares subject to, or the value of, outstanding vested or unvested equity awards; and/or

7.
Taking any other remedial and recovery action permitted by law, as determined by the Committee.

The Committee will consider Section 409A of the U.S. Internal Revenue Code of 1986, as amended, prior to offsetting recouped amounts against future payments of deferred compensation.
 
F.    No Indemnification or Insurance
 
Neither the Company nor any of its subsidiaries or affiliates shall indemnify any Covered Executive against the loss of any Erroneously Awarded Compensation.  Further, neither the Company nor any of its subsidiaries or affiliates shall pay or reimburse any Covered Executive for any insurance policy entered into by a Covered Executive that provides for full or partial coverage of any recoupment obligation under this Policy.
 
G.    Amendment; Termination
 
The Board or the Committee may amend this Policy from time to time in its discretion in any manner consistent with applicable law and regulation.  The Board or Committee may terminate this Policy at any time when the Company does not have a class of securities listed on a national securities exchange or a national securities association.
 

H.    Other Recoupment Rights
 
The Board intends that this Policy will be applied to the fullest extent of the law.  Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company pursuant to the terms of the Company’s code of conduct, any similar policy or recoupment provision in any employment agreement, equity award agreement, bonus plan, or similar agreement or plan and any other legal remedies available to the Company (collectively, “Other Recoupment Provisions”).  Further, the provisions of this Policy are in addition to (and not in lieu of) any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002 and other applicable laws. However, there shall be no duplication of recovery under this Policy, Other Recoupment Provisions, or the Sarbanes-Oxley Act.
 
I.    Successors
 
This Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators, or other legal representatives.
 
J.    Disclosure
 
The circumstances of any recoupment pursuant to this Policy will be publicly disclosed where required by Rule 10D-1, Item 402 of Regulation S-K and Section 303A.14.  In accordance with Rule 10D-1, the Policy shall be filed with the SEC as an exhibit to the Company’s Form 10-K, as provided in Item 601(b) of Regulation S-K.

K.    Change of Listing
 
In the event that the Company lists its securities on any national securities exchange or national securities association other than the NYSE, all references to “NYSE” in this Policy shall mean each national securities exchange or national securities association upon which the Company has a class of securities then listed and “Section 303A.14” shall mean the rule(s) relating to recovery of erroneously awarded compensation under the listing rules of such other applicable exchange or association.

L.    Acknowledgement
 
Each Executive Officer will be required to sign a statement, in a form to be approved by the Committee, acknowledging receipt of this Policy and agreeing to comply with it. This Policy will be binding on all Covered Executives regardless of whether such acknowledgement is executed.

M.    Governing Law and Venue
 
This Policy and all determinations made and actions taken hereunder, to the extent not otherwise governed by the laws of the United States, shall be governed by the laws of the State of Utah, United States of America, without reference to principles of conflict of laws, and construed accordingly. The jurisdiction and venue for any disputes arising under, or any actions brought to enforce (or otherwise relating to), the Policy will be exclusively in the courts of Utah County, Utah or the federal courts of the United States for the District of Utah (should federal jurisdiction exist).




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed as of:2/15/24
Filed on:2/14/244,  8-K
For Period end:12/31/23
11/9/23
10/2/23
11/28/224
 List all Filings 


14 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/06/24  Nu Skin Enterprises, Inc.         8-K:5,9     2/05/24   11:308K                                   Broadridge Fin’l So… Inc
 8/02/23  Nu Skin Enterprises, Inc.         10-Q        6/30/23   72:7.5M                                   Broadridge Fin’l So… Inc
 2/16/23  Nu Skin Enterprises, Inc.         10-K       12/31/22  126:15M                                    Broadridge Fin’l So… Inc
 6/17/22  Nu Skin Enterprises, Inc.         8-K:1,2,9   6/14/22   11:1.7M                                   Broadridge Fin’l So… Inc
 2/16/22  Nu Skin Enterprises, Inc.         10-K       12/31/21  121:14M                                    Broadridge Fin’l So… Inc
 2/11/21  Nu Skin Enterprises, Inc.         10-K       12/31/20  120:13M                                    Broadridge Fin’l So… Inc
10/20/20  Nu Skin Enterprises, Inc.         8-K:5,9    10/15/20   12:536K                                   Broadridge Fin’l So… Inc
 6/03/20  Nu Skin Enterprises, Inc.         S-8         6/03/20    4:355K                                   Broadridge Fin’l So… Inc
 2/13/20  Nu Skin Enterprises, Inc.         10-K       12/31/19  124:14M                                    Broadridge Fin’l So… Inc
11/04/16  Nu Skin Enterprises, Inc.         10-Q        9/30/16   62:3.7M
 5/24/16  Nu Skin Enterprises, Inc.         8-K:5,9     5/24/16    2:189K
 3/01/10  Nu Skin Enterprises, Inc.         10-K       12/31/09   11:3.1M
 3/15/05  Nu Skin Enterprises, Inc.         10-K       12/31/04   13:1.4M                                   Tillotson Sandra
 9/16/96  Nu Skin Enterprises, Inc.         S-1                   29:977K                                   Donnelley Fin’l S… 01/FA
Top
Filing Submission 0001140361-24-008111   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 2:07:12.2pm ET